Erythropoietin (EPO) Market
Pharmaceuticals

Global Erythropoietin (EPO) Market Overview And Prospects

Learn about the global erythropoietin (EPO) market through The Business Research Company, which provides information on erythropoietin (EPO) market size, erythropoietin (EPO) market drivers and restraints, erythropoietin (EPO) market players, the COVID-19 impact on the erythropoietin (EPO) market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global erythropoietin (EPO) market is expected to grow from $0.96 billion in 2020 to $1.1 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The EPO market is expected to reach $3.11 billion in 2025 at a CAGR of 30%.

The rising incidence of chronic kidney diseases is expected to drive innovation in EPO manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Erythropoietin (EPO) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smph

The erythropoietin market consists of sales of erythropoietin drugs by entities (organizations, sole traders, and partnerships) that manufacture erythropoietin biosimilars. Erythropoietin is a hormone produced by kidneys and plays a vital role in the production of red blood cells, which carry oxygen from the lungs to the rest of the body. Lack of sufficient erythropoietin results in low red blood cells, which may lead to anaemia. EPO drugs are used for treatment for anaemia, kidney disorders, cancer, and other conditions.

Global erythropoietin (EPO) market segments include:

By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others

By Application: Cancer, Hematology, Renal Diseases, Neurology, Others

By Drug Class: Biologis, Biosimilar

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Stringent regulations imposed on the production and sales of erythropoietin drugs are predicted to hinder the growth of the erythropoietin market over the forecast period.

TBRC’s erythropoietin market report covers:

Major Market Players: Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides erythropoietin (EPO) market overviews, analyzes and forecasts market size, share, erythropoietin (EPO) market players, erythropoietin (EPO) market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s erythropoietin (EPO) market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Therapeutic Proteins Global Market Report 2021

Pharmaceutical Drugs And Biologics Logistics Market

Pharmaceuticals Global Market Report 2021

Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *